Dexcom G7 sensors
Ended Awarded Last action
- Contract number
- SPE2DR26F0A6X
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,164
Award facts
- Contract value 100% obligated
- $29,163.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $29,163.62 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 29, 2026, for the supply of Dexcom G7 continuous glucose monitoring sensors. This is a non-set-aside competitive award with performance completion targeted for January 30, 2026, and fulfillment from Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement through December 2026 that enables comprehensive global pharmaceutical and medical supply support to military healthcare systems worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of parent company Cencora, Inc. (UEI: NWEGNLYTBDW4), which also conducts business under the Amerisourcebergen name. Both entities function as critical pharmaceutical distributors within the federal medical procurement ecosystem, with Cencora holding its own significant $999,999,999.00 IDC with the DLA Troop Support Medical through December 31, 2031. The supply of Dexcom G7 sensors supports military healthcare programs' diabetes management and chronic disease monitoring requirements across the Defense Health Agency and related federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F0A6X?
SPE2DR26F0A6X was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F0A6X worth?
The government has obligated $29,164 on SPE2DR26F0A6X.
Is contract SPE2DR26F0A6X an order under another contract?
Yes. SPE2DR26F0A6X is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F0A6X competed?
The extent of competition for SPE2DR26F0A6X was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award